Pharmaceutical compositions comprising hepatitis c viral protease inhibitors

摘要: Disclosed are pharmaceutical compositions of hepatitis C viral protease inhibitors having improved bioavailability, and methods using these for inhibiting the replication virus (HCV) treatment an HCV infection. These include co-solvent systems, lipid based solid dispersions granulations, all comprise inhibitor, at least one pharmaceutically acceptable amine optionally or more additional ingredients.